Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-030102
Filing Date
2025-02-28
Accepted
2025-02-28 16:36:59
Documents
94
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K aldx-20241231.htm   iXBRL 10-K 2706985
2 EX-10.25 aldx-ex10_25.htm EX-10.25 151163
3 EX-10.27 aldx-ex10_27.htm EX-10.27 12203
4 EX-19.1 aldx-ex19_1.htm EX-19.1 268007
5 EX-21.1 aldx-ex21_1.htm EX-21.1 8594
6 EX-23.1 aldx-ex23_1.htm EX-23.1 3902
7 EX-31.1 aldx-ex31_1.htm EX-31.1 13128
8 EX-31.2 aldx-ex31_2.htm EX-31.2 13020
9 EX-32.1 aldx-ex32_1.htm EX-32.1 15337
10 EX-97 aldx-ex97.htm EX-97 52536
11 GRAPHIC img130913613_0.jpg GRAPHIC 217861
12 GRAPHIC img130913613_1.jpg GRAPHIC 247110
13 GRAPHIC img130913613_2.jpg GRAPHIC 138163
14 GRAPHIC img130913613_3.jpg GRAPHIC 64993
15 GRAPHIC img130913613_4.jpg GRAPHIC 69968
16 GRAPHIC img130913613_5.jpg GRAPHIC 122871
17 GRAPHIC img130913613_6.jpg GRAPHIC 196886
18 GRAPHIC img130913613_7.jpg GRAPHIC 74412
  Complete submission text file 0000950170-25-030102.txt   13430322

Data Files

Seq Description Document Type Size
19 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aldx-20241231.xsd EX-101.SCH 1420997
96 EXTRACTED XBRL INSTANCE DOCUMENT aldx-20241231_htm.xml XML 1547687
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36332 | Film No.: 25691076
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)